Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series
Tacrolimus is a cornerstone immunosuppressant in transplantation medicine with a narrow therapeutic window. Drug–drug interactions with strong CYP3A4 and P‐glycoprotein modulators, such as rifampin and azole antifungals, significantly alter tacrolimus exposure and complicate therapy. Two transplant cases illustrates the impact of rifampin on tacrolimus
Jeroen P. A. Houwen +6 more
wiley +1 more source
Development of a novel family of antifungal agents based on a quinone methide oxime framework. [PDF]
Janeczko M +14 more
europepmc +1 more source
Fungal Diseases in Elasmobranchs and Their Possible Treatment with a Special Mention to Azole Antifungal Agents. [PDF]
Cañizares-Cooz D +5 more
europepmc +1 more source
Cytochrome P-450 as a target of azole antifungal agents.
Yuzou YOSHIDA
openalex +2 more sources
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients [PDF]
Mónica Chávez +5 more
openalex +1 more source
Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah +9 more
wiley +1 more source
Synthesis, characterization and bio-evaluation of novel series of pyrazoline derivatives as potential antifungal agents. [PDF]
Yadav CS +11 more
europepmc +1 more source
Restricticin, a novel glycine-containing antifungal agent.
Robert E. Schwartz +15 more
openalex +2 more sources
Study of the Effective Dose of a Topical Antifungal Agent, Omoconazole Nitrate, on the Basis of Percutaneous Pharmacokinetics in Guinea-pigs and Mice [PDF]
Terushi Hashiguchi +4 more
openalex +1 more source

